Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Oct;101(10):1038-1047.
doi: 10.1111/aogs.14356. Epub 2022 Apr 7.

Multivitamin use and risk of preeclampsia: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Multivitamin use and risk of preeclampsia: A systematic review and meta-analysis

Cecilie Holm Christiansen et al. Acta Obstet Gynecol Scand. 2022 Oct.

Abstract

Introduction: Preeclampsia is associated with adverse maternal and neonatal outcomes. It is unclear whether multivitamin use reduces the risk of preeclampsia. This systematic review and meta-analysis aimed to evaluate the association between multivitamin use and the risk of preeclampsia.

Material and methods: We searched PubMed, Embase and the Cochrane Library from database inception to July 2021. Randomized controlled trials (RCTs), case-control and cohort studies assessing the association between multivitamin use and risk of preeclampsia were eligible. Studies of treatment with a single micronutrient were excluded. Relative risks and 95% confidence intervals (95% CI) were calculated using random-effects models. RoB2, the Newcastle Ottawa Scale and GRADE were used to assess risk of bias and quality of evidence. The protocol was registered in PROSPERO (no. CRD42021214153).

Results: Six studies were included (33 356 women). Only two RCTs were found, both showing a significantly decreased risk of preeclampsia in multivitamin users. These studies were not compatible for meta-analysis due to clinical heterogeneity. A meta-analysis of observational studies using a random-effects model showed an unchanged risk of preeclampsia following multivitamin use (relative risk 0.85, 95% CI 0.69-1.03). The quality of evidence according to GRADE was very low.

Conclusions: Very weak evidence suggests that multivitamin use might reduce the risk of preeclampsia; however, more research is needed. Large RCTs should be prioritized. The results of this review do not allow any final conclusions to be drawn regarding a preventive effect of multivitamin use in relation to preeclampsia.

Keywords: HELLP; eclampsia; micronutrients; multivitamin; preeclampsia; pregnancy; pregnant women.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

FIGURE 1
FIGURE 1
Flow chart of search results and process for selection and inclusion of references in systematic review
FIGURE 2
FIGURE 2
Meta‐analyses. Forest plots of effect estimates for preeclampsia

Comment in

References

    1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1‐7. - PubMed
    1. Vigil‐De GP. Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynecol Obstet. 2009;104:90‐94. - PubMed
    1. World Health Organization International Classification of Diseases and Related Health Problems, 10th Revision. World Health Organization; 2016. Contract No.:May 22.
    1. Sjónsdóttir L, Arngrimsson R, Geirsson RT, Slgvaldason H, Slgfússon N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1995;74:772‐776. - PubMed
    1. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet. 2001;357:2002‐2006. - PubMed